Glenspray active spray nasal dosed suspension bottle 75 doses with spray pump

Glenspray Active nasal spray is indicated for seasonal allergic rhinitis.

Composition

Active ingredients: mometasone furoate and azelastine hydrochloride;

1 dose contains mometasone furoate 50 mcg and azelastine hydrochloride 140 mcg;

Excipients: microcrystalline cellulose and sodium carboxymethylcellulose; sodium carmellose; anhydrous glucose; polysorbate 80 benzalkonium chloride, trilon B; He from; citric acid monohydrate, sodium; water for injections.

Contraindication

Method of application

The drug is intended for intranasal use only.

Adults and children over 12 years of age, the recommended dose is 1 spray in each nostril 2 times a day.

Before each use, shake the bottle gently for 5 seconds. Then remove the protective cap. Before using the bottle for the first time, press the dosing device 6 times in a row. If the nasal spray has not been used for more than 7 days, press the dosing pump-sprayer again 6 times in a row before use.

Before each use, thoroughly clean the nose from mucus. After cleaning the nose, the suspension is injected into each nostril, while the head should not be tilted down. After use, the spray tip should be wiped and covered with a protective cap.

Application features

Pregnant women

Not applicable.

Children

There is no sufficient clinical experience with the drug in children under 12 years of age, so it should not be used in patients of this age category.

Drivers

During treatment, patients should refrain from work that requires increased concentration and speed of reactions.

Overdose

In case of acute overdose, central nervous system disorders (drowsiness, dizziness) are possible. Oral single administration of azelastine hydrochloride in doses up to 16 mg during clinical studies did not lead to an increase in the frequency of serious side effects. Treatment is symptomatic. There is no known antidote.

Side effects

The most common adverse reactions were headache and dysgeusia. Other adverse reactions were drowsiness, lethargy, nausea, dyspepsia, and sneezing. Most adverse reactions were mild in severity, and no serious adverse reactions were reported during the study.

Interaction

Concomitant use of azelastine with alcohol or other central nervous system depressants may result in decreased concentration and deterioration of central nervous system function.

Storage conditions

Store in a dark place at a temperature not exceeding 25 °C. Do not freeze.

Keep out of reach of children.

Shelf life - 2 years.